The Department of Health advise that schoolchildren who show strongly positive tuberculin reactions when routinely tested under the BCG vaccination programme at around the age of 13 should be referred for further investigation and supervision (which may include prophylactic chemotherapy).'2 Current policy in Leicestershire is to perform Heaf tests on schoolchildren at the age of 12-13 years. Those with strongly positive reactions (grades 3 and 4) have chest radiographs taken, but if these are normal then no action is taken and no chemoprophylaxis is given. There is a risk that some of these will "break down" and develop clinical tuberculosis, which might otherwise be prevented with isoniazid prophylaxis. Many children, however, may be treated unnecessarily. Immense clinic resources will be needed, and drug related side effects, though rare, are possible. Compliance may be low as patients will not feel "ill." It would therefore be helpful to know the "breakdown" rate in this population, to give some estimate of the likely benefit from prophylaxis.
The problem is particularly acute in Leicestershire with its large Asian community, and as there is little information about this population we decided to study only this group.
Method
Notification forms used by health visitors for contact tracing are a complete record of tuberculosis notifications in Leicestershire. These records for the five years 1983-7 were scanned for children with Asian sounding names born around 1970 and therefore aged around 12 or 13 in 1982 and 1983.
These names of children with active tuberculosis were then compared with the lists of those children who had a grade 3 or 4 Heaf test reaction in 1982 and 1983. Dates of birth and addresses were compared as a further check because of the similarity of many Asian names. From these figures a "breakdown" rate was calculated.
Results

Tuberculosis notifications in all groups in
Leicestershire for the years 1983-7 ranged from 159 to 241/year. In Edinburgh 89 590 (mostly white) children in the schools' programme were followed for a mean of seven years. 4 Of 390 children with grade 3 or 4 Heaf test teactions, 13 were subsequently notified as having tuberculosis. Nine of these had an initial abnormal chest radiograph, leaving four (about one in 100) children tested who might benefit from prophylaxis. This might be considered worth while, especially as only 5% of the whole population had received BCG when younger.
A British Thoracic Association survey5 on the efficacy of BCG vaccination showed an annual breakdown rate in those with a positive Heaf test reaction of 22/100 000, but this included all grades.
Ormerod6 showed that the introduction of a policy of prophylactic chemotherapy was associated with reduced notification rates in children, but he included contacts of cases, new immigrants, and recent Heaf converters as well as those detected by routine testing. The decline he showed could be due to the fact that later cohorts of children were born in the UK and received BCG vaccination at birth, as recommended by the Department of Health.
The recent code of practice of the British Thoracic Society7 on tuberculosis control recommends that tuberculin positive children who are new immigrants or recent contacts should receive prophylaxis but does not consider the schools' BCG programme. Advice from the same body' on the management of tuberculosis is to give prophylaxis to children with strongly positive Heaf test reactions but it does not qualify this advice.
Tuberculosis in small children is a potentially most damaging disease and therefore prevention would be worth while. Prophylaxis at 13, however, prevents disease only in adolescents and adults. Our conclusion is that routine prophylaxis is not justified for this group of Asian children with strongly positive tuberculin test reactions, most of whom have received BCG vaccine in early life, so long as the chest radiographs are clear. Resources should be concentrated on early detection of tuberculosis in patients with symptoms. 
